title: CpG oligonucleotides protect against Venezuelan equine encephalitis virus infection in a route-dependent manner.
authors.affiliation: Biomedical Sciences Department, Defence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK.
authors.forename: D G Cerys
authors.initials: DG
authors.lastname: Rees
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Phillpotts
authors.forename: Kate F
authors.initials: KF
authors.lastname: Griffin
authors.forename: Roman A
authors.initials: RA
authors.lastname: Lukaszewski
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Laws
authors.forename: Helen S
authors.initials: HS
authors.lastname: Atkins
authors.forename: Arthur M
authors.initials: AM
authors.lastname: Krieg
authors.forename: Richard W
authors.initials: RW
authors.lastname: Titball
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000281:Administration, Intranasal; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage*; D018890:Chemoprevention / Q000379:methods*; D004195:Disease Models, Animal; D004666:Encephalitis Virus, Venezuelan Equine / Q000187:drug effects*; D004685:Encephalomyelitis, Venezuelan Equine / Q000517:prevention & control*; D005260:Female; D007279:Injections, Subcutaneous; D051379:Mice; D008807:Mice, Inbred BALB C; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage*; D009841:Oligonucleotides; D016019:Survival Analysis
chemical_list: D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; C408982:CPG-oligonucleotide; D009838:Oligodeoxyribonucleotides; D009841:Oligonucleotides